tiprankstipranks
Faes Farma SA (GB:0K9H)
LSE:0K9H

Faes Farma (0K9H) Income Statement

1 Followers

Faes Farma Income Statement

Last quarter (Q ), Faes Farma's total revenue was €121.03M, a decrease of -5.93% from the same quarter last year. In Q, Faes Farma's net income was €21.09M. See Faes Farma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
€ 429.71M€ 398.56M€ 380.24M€ 357.40M€ 324.31M€ 274.58M
Cost of Revenue
€ 160.03M€ 146.16M€ 140.40M€ 129.99M€ 120.18M€ 96.44M
Gross Profit
€ 269.68M€ 252.40M€ 239.84M€ 227.41M€ 204.13M€ 178.14M
Operating Expense
€ 167.80M€ 153.53M€ 147.27M€ 147.97M€ 141.57M€ 128.43M
Operating Income
€ 101.88M€ 98.87M€ 92.57M€ 79.44M€ 62.56M€ 49.71M
Net Non Operating Interest Income Expense
€ -346.00K€ -592.00K€ -396.00K€ -303.00K€ -404.00K€ -213.00K
Other Income Expense
------
Pretax Income
€ 97.25M€ 93.99M€ 84.88M€ 74.17M€ 61.73M€ 49.50M
Tax Provision
€ 11.13M€ 10.78M€ 11.51M€ 10.15M€ 9.93M€ 8.02M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ 85.99M€ 83.16M€ 72.55M€ 63.96M€ 51.59M€ 41.38M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-€ 1.74M€ 1.20M€ 954.00K€ 2.42M€ 2.08M
Total Expenses
€ 327.83M€ 299.69M€ 287.67M€ 277.96M€ 261.75M€ 224.87M
Net Income From Continuing And Discontinued Operation
€ 85.99M€ 83.16M€ 72.55M€ 63.96M€ 51.59M€ 41.38M
Normalized Income
€ 85.99M€ 86.91M€ 77.42M€ 67.92M€ 51.90M€ 40.21M
Interest Expense
-€ 216.00K€ 266.00K€ 51.00K€ 256.00K€ 211.00K
EBIT
€ 97.22M€ 94.20M€ 85.15M€ 74.23M€ 61.99M€ 49.71M
EBITDA
€ 116.00M€ 110.44M€ 99.97M€ 86.91M€ 72.24M€ 58.18M
Currency in EUR

Faes Farma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis